Bottom line
Is SSILX a good fund? The bottom line
SSILX is the Class A share class of State Street International Stock Selection Fund, an actively managed international stock mutual fund from SPDR (State Street).
Its expense ratio is 1.2% — about $120 a year on every $10,000 invested, more expensive than 76% of international stock funds we track.
It returned +1.9% over one year, +3.1% a year over five years, +3.2% a year over ten (as of Dec 31, 2024, per its prospectus).
With $237 million in net assets and 196 holdings, its largest position is State Street Global Advisors (5.4%) and the top 10 make up 20.6% of the portfolio.
This share class carries a front-end sales charge of up to 5.25%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.2%)
- 5-year return in the bottom quarter of its category
- Front-end sales load up to 5.25%
- 12b-1 marketing fee of 0.25% a year
- High turnover (131% a year) can mean more taxable distributions
Updated Nov 19, 2026
What SSILX invests in
State Street International Stock Selection Fund (the Fund) seeks to provide long-term capital growth by investing primarily in securities of foreign issuers.
The Fund will invest at least 80% of its net assets (plus borrowings, if any) in equity securities of foreign issuers, such as common stocks issued by companies in the countries and industries represented in the MSCI EAFE Index, the Fund's benchmark. The Fund may invest in small capitalization companies. The Fund will provide shareholders with at least sixty (60) days' notice prior to any change in its 80% investment policy. The Adviser employs a proprietary quantitative multi-factor stock-selection model to select securities while controlling risk exposure of the Fund relative to the Fund's benchmark. This model evaluates the relative attractiveness of securities from a specified investment universe based on the correlation of certain historical economic and financial factors applicable to issuers and/or countries and/or sectors (such as measures of valuation, quality and investor…
From the fund's prospectus (filed Dec 18, 2025).
SSILX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SSILX | +1.9% | +3.1% | +3.2% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2024
What SSILX costs
On a $10,000 investment, SSILX's 1.2% expense ratio costs about $120 a year. The prospectus estimates $2,139 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
SSILX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | State Street Global Advisors | 5.41% |
| 2 | Novartis AG | 2.27% |
| 3 | Roche Holding AG | 1.99% |
| 4 | BHP Group Ltd | 1.89% |
| 5 | ASML Holding NV | 1.78% |
| 6 | TDK Corp | 1.63% |
| 7 | Gsk Plc | 1.44% |
| 8 | Barclays PLC | 1.41% |
| 9 | Lloyds Banking Group PLC | 1.39% |
| 10 | Deutsche Telekom AG | 1.38% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 20.6% of the fund. See all top 25 holdings and asset mix →